Cardinal Health, Inc. (CAH)
NYSE · Healthcare · Medical - Distribution
Profile
Cardinal Health, Inc.
- Exchange
- NYSE
- Ticker
- CAH
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- US
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Key facts
Cardinal Health, Inc.: key facts
- Cardinal Health, Inc. (NYSE: CAH) is a Medical - Distribution company in the Healthcare sector.
- In fiscal 2026, Cardinal Health, Inc. reported revenue of $254.2B and net income of $1.7B.
- Revenue grew 8.8% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 4 of the last 5 fiscal years.
- Over the last twelve months, revenue was $254.2B and net income was $1.7B.
MonkScore
Cardinal Health, Inc.'s MonkScore
MonkScore
MonkScore range: 70–80
as of October 2026
Sector rank: 209 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth70–80
- Profitability80–90
- Quality50–60
- Market Conviction30–40
- Safety50–60
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
Cardinal Health, Inc.'s annual figures and the last twelve months, in USD. Last report: 30 June 2026.
| Figure | Last 12 months | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Revenue | $254.2B | $254.2B | $222.6B | $226.8B | $205.0B | $181.3B |
| Gross profit | $9.8B | $9.8B | $8.2B | $7.4B | $6.9B | $6.5B |
| Operating income | $2.6B | $2.6B | $2.3B | $1.2B | $752.0M | -$607.0M |
| Net income | $1.7B | $1.7B | $1.6B | $852.0M | $330.0M | -$938.0M |
| Operating cash flow | $5.2B | $5.2B | $2.4B | $3.8B | $2.8B | $3.1B |
| Capital expenditure | -$649.0M | -$649.0M | -$547.0M | -$511.0M | -$481.0M | -$387.0M |
| Free cash flow | $4.5B | $4.5B | $1.9B | $3.3B | $2.4B | $2.7B |
| Total debt | $9.9B | $9.9B | $9.3B | $5.6B | $5.2B | $5.8B |
| Cash | $4.9B | $4.9B | $3.9B | $5.1B | $4.1B | $4.7B |
Revenue growth a year
- 1-year
- 14.2%
- 3-year
- 7.4%
- 4-year
- 8.8%
Compound growth between fiscal years.
Peers
Similar companies
- McKesson CorporationNYSE:MCKMonkScore range: 70–80
- Cencora, Inc.NYSE:CORMonkScore range: 70–80
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.